Login / Signup

[Experience of clinical use of fluvoxamine for the treatment of comorbid depression in childhood and adolescence].

A V GoryunovN I GolubevaO V Shushpanova
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
The use of the fluvoxamine provides reduction of depressive symptoms within the framework of various nosologies, and is characterized by sufficient safety. The variety of therapeutic targets of the fluvoxamine, including antidepressant, anti-anxiety, cognitive effects, is certainly a significant advantage of the studied fluvoxamine for use in childhood.
Keyphrases
  • depressive symptoms
  • sleep quality
  • social support
  • major depressive disorder
  • early life
  • childhood cancer
  • combination therapy
  • bipolar disorder
  • physical activity